Changchun Medike Intelligent Driving Auto Tech Co., Ltd. has recently announced the successful completion of its Pre-A round financing, securing tens of millions of yuan. This round of financing has drawn in new shareholders, including CAS Star and Shenzhen Innovation Investment Group, and has also seen the involvement of three funds managed by Jilin provincial state-owned investment entities. The capital raised will be channeled primarily into research and development, product innovation, service optimization, and the establishment of a robust market system. Prior to this, Medike had already secured 5 million yuan in seed funding in 2024, experiencing a fivefold increase in its valuation within just a year.
As a nationally recognized high-tech enterprise, Medike is dedicated to the research and development of automatic wheel intelligent driving chassis technology tailored for new energy intelligent connected vehicles. The company boasts a portfolio of core technologies and patents. Notably, its independently developed corner module technology offers significant advantages, effectively tackling key challenges within the industry. The founder of the company, Jin Liqiang, has made remarkable achievements in scientific research.
Currently, Medike has transitioned from a phase of 'technical acknowledgment' to 'product acknowledgment'. This latest round of financing is poised to expedite the enhancement of its marketing and service capabilities. Looking ahead, the company has outlined a market strategy for 2026 that involves 'deepening internal operations, expanding externally, and ensuring backward compatibility'. Jin Liqiang emphasized that the new funding will propel the company to strengthen its infrastructure, foster business expansion, and refine its governance framework.